Cynaptec Pharmaceuticals, Inc. — Form D
Cynaptec Pharmaceuticals, Inc. of STUART, FL, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-17. The offering totals $26.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-04-17
- Form: D
- Accession: 0002058683-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $26.0M
- Amount sold: $6.0M
- Remaining: $20.0M
- Investors: 1
- Date of first sale: 2025-04-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-543937
Issuer
- Name: Cynaptec Pharmaceuticals, Inc.
- CIK: 0002058683
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 4244 SE CENTERBOARD LANE, STUART, FL, 34997
- Phone: 561-891-1737
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| CHARLES F GOULBURN II | Director | STUART, FL |
| WESLEY F RAMJEET | Director | STUART, FL |
| SETH F RODNER | Director | STUART, FL |
| FREDERICK SANCILIO | Director | STUART, FL |
| JONAH F SHACKNAI | Director | STUART, FL |
| FREDERICK SANCILIO | Executive Officer | STUART, FL |
More